However, in contrast, androgen-receptor signaling can also promote tumor progression under certain conditions, especially in triple-negative breast cancer (TNBC), where AR expression is often associated with more aggressive disease and poorer outcomes [59,63,64]. The gene discussed is AR; the disease is neoplasm.